argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
887.18
-1.47 (-0.17%)
At close: Jun 26, 2026, 4:00 PM EDT
897.59
+10.41 (1.17%)
After-hours: Jun 26, 2026, 7:12 PM EDT
argenx SE Employees
argenx SE had 1,863 employees as of December 31, 2025. The number of employees increased by 264 or 16.51% compared to the previous year.
Employees
1,863
Change (1Y)
264
Growth (1Y)
16.51%
Revenue / Employee
$2,545,609
Profits / Employee
$799,267
Market Cap
55.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,863 | 264 | 16.51% |
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 148 | 78.72% |
| Dec 31, 2019 | 188 | 83 | 79.05% |
| Dec 31, 2018 | 105 | 32 | 43.84% |
| Dec 31, 2017 | 73 | 15 | 25.86% |
| Dec 31, 2016 | 58 | 17 | 41.46% |
| Dec 31, 2015 | 41 | 9 | 28.13% |
| Dec 31, 2014 | 32 | 10 | 45.45% |
| Dec 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Vertex Pharmaceuticals | 6,400 |
| Moderna | 4,700 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
ARGX News
- 1 day ago - ARGX Reiterates by HC Wainwright & Co. -- Price Target Maintained at $940 - GuruFocus
- 2 days ago - ARGX Maintained by Morgan Stanley -- Price Target Raised to $1180 - GuruFocus
- 2 days ago - Can Argenx Retake Its Record High — And A Buy Point — On A New Vyvgart Strategy? - Investor's Business Daily
- 2 days ago - Argenx price target raised to $1,180 from $1,170 at Morgan Stanley - TheFly
- 3 days ago - argenx SE Transcript: Status update - Transcripts
- 14 days ago - argenx Eyes More VYVGART Growth as Pipeline Catalysts Near - MarketBeat
- 17 days ago - argenx SE Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 21 days ago - argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference - MarketBeat